Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
120.50    0.00 (0.00%)
Bid:
118.00
Ask:
123.00
Spread: 5.00 (4.237%)
Market Cap: £72.50m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

New Reseller Partnership

17 Nov 2008 07:00

RNS Number : 2408I
Intercede Group PLC
17 November 2008
 



17 November 2008 

INTERCEDE GROUP plc

("Intercede" or "the Company")

New Reseller Partnership

Intercede and ORC Partner for PIV Programs 

and Deliver Managed Credentialing Service to US Military Contractors

Intercede (AIM:IGP), the producer of the Intercede MyID® Identity and Credential Management System (IDCMS) announces that Operational Research Consultants, Inc. ("ORC"), a subsidiary of WidePoint Corporation (AMEX: WYY), has signed a Solutions Partnership contract with Intercede. Under this contract ORC will resell and support MyID solutions and services to US Federal, State and commercial customers. A number of ORC customers already use MyID powered servicesincluding the United Space Alliance, Federal Trade Commission, Federal Housing Finance Administration and the Federal Election Commission. The credentials they use are fully compliant with the Federal Information Processing Standards No. 201 ("FIPS 201"), a new U.S. Federal Standard that sets out stringent requirements of Personal Identity Verification ("PIV") for all Federal employees and contractors.

Under a separate agreement, ORC is using Intercede MyID to deliver medium hardware assurance credentials and associated certificates to contractors that service the U.S. Military, worldwide. This service is a key component in a Defense industry-wide identity and cross-credentialing network build on certified products and standards. This network is being built as a private industry initiative to verify and authenticate the identity of civilian personnel seeking to enter U.S. Military installations. The credentials issued under this program are recognized by the U.S. Department of Defense (DoD) as providing the same level of identity assurance as the Common Access Card (CAC) carried by all U.S. DoD personnel.

As part of an early stage deployment, ORC has already purchased several thousand Intercede MyID licenses for deployment for access to selected U.S. Military bases. 

Intercede Chairman & Chief Executive, Richard Parris said;

"ORC is an important new partner for Intercede, servicing U.S. Federal Government customers with PIV credentials. ORC's choice of Intercede's MyID to securely issue certified credentials to contractors servicing the U.S. Military is further testament to the strength of Intercede's technology. This emerging opportunity is potentially much larger than the U.S. DoD Common Access Card market and ORC is in an excellent position to exploit this market as it develops."

ORC Chief Executive, Dan Turissini said;

"We are working with Intercede's MyID system to deliver secure credentials to the U.S. Government because it gives ORC a competitive advantage in supporting our nation's critical infrastructure protection. Using MyID we were able to deploy, using a single product, a full end-to-end identity and credentialing system in a fraction of the time and cost compared to using a more traditional systems integration approach. Our systems are now in full production and ready to support millions of credentials in the coming months and years."

About WidePoint

WidePoint is a leading provider of advanced information technology products and services including identity management and information assurance and protection services, forensic informatics and wireless technology services. WidePoint has several wholly owned subsidiaries holding major contracts, Operational Research Consultants, Inc., iSYS, LLC, Protexx, Inc. and WidePoint IL. WidePoint enables organizations to deploy fully compliant IT services in accordance with government-mandated regulations and advanced system requirements. For more information, visit www.widepoint.com. 

An investment profile about WidePoint may be found at www. hawkassociates.com/profile/wyy.cfm.

 For investor relations information regarding WidePoint, visit www.hawkassociates.com and  www.americanmicrocaps.com, or contact Frank Hawkins or Cale Smith, Hawk Associates, at 305-451-1888, e-mail: widepoint@hawkassociates.com. To receive notification of future releases via e-mail, subscribe at www.hawkassociates.com/about/alert/.

About Intercede

  Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and lifecycle management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments include 10 US Federal Agencies, the US Transportation Worker Identity Credential (TWIC) and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

For more details visit www.intercede.com

ENQUIRIES

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

Pelham Public Relations

Tel. +44 (0)20 7743 6679

Archie Berens

Robert Koh

KBC Peel Hunt

Tel. + 44 (0)20 7418 8900

Richard Kauffer

Daniel Harris

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFFUFWLSASEFF
Date   Source Headline
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.